Who owns ALNYLAM PHARMACEUTICALS, INC. (ALNY)? Elite investor 13F holders
5 tracked elite investors reported holding ALNYLAM PHARMACEUTICALS, INC as of 2026-06-30, including Dodge & Cox Funds, D.E. Shaw, Bridgewater Associates, Gotham Asset Management, Ancora Advisors / Ancora Holdings. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
5 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally. The company offers ONPATTRO for hereditary transthyretin-mediated (hATTR) amyloidosis; AMVUTTRA for ATTR and hATTR amyloidosis; Leqvio for hypercholesterolemia; Qfitlia for hemophilia A or B; GIVLAARI for acute…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Dodge & Cox Funds | ALNYLAM PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 588631955.00 USD | 1955393.000000 | Shares | add | Original filing |
| D.E. Shaw | ALNYLAM PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 332369932.00 USD | 1104109.000000 | Shares | add | Original filing |
| Bridgewater Associates | ALNYLAM PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 29977772.00 USD | 99584.000000 | Shares | reduce | Original filing |
| Gotham Asset Management | ALNYLAM PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 12658613.00 USD | 42051.000000 | Shares | reduce | Original filing |
| Ancora Advisors / Ancora Holdings | ALNYLAM PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 3311.00 USD | 11.000000 | Shares | hold | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.